Skip to main content
SpringerLink
Log in

The p27/Kip1 Locus Shows No Loss of Heterozygosity in Human Pituitary Adenomas

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Thapar K, Kovacs K, Laws ER: Pituitary Tumors. In: Black, PM and Loeffler, JS (eds), Cancer of the Nervous System, pp 363–403. Cambridge: Blackwell Science, lnc., 1997

  2. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM: A syndrome of hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85: 733–44, 1996

    Article  PubMed  Google Scholar 

  3. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, HaydayAC, Frohman LA, Koff A: Enhanced growth of mice lacking the cyclindependent kinase inhibitor function of p27(Kip1). Cell 85: 721–32, 1996

    Article  PubMed  Google Scholar 

  4. Nakayama K, Ishida N, Shirane, M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K: Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85: 707–20, 1996

    Article  PubMed  Google Scholar 

  5. Firpo EJ, Koff A, Solomon MJ, Roberts JM: Inactivation of a Cdk2 inhibitor during interluekin 2–induced proliferation of human T lymphocytes. Mol Cell Biol 14: 4889–901, 1994

    PubMed  Google Scholar 

  6. Hengst L, Dulic V, Slingerland JM, Lees E, Reed SI: A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci USA 91: 5291–5, 1994

    PubMed  Google Scholar 

  7. Polyak, K, Kato, JY, Solomon, MJ, Sherr, CJ, Massague, J, Roberts, Jm, Koff, A: p27Kip1, 4 activation. Cell 79: 487–96, 1994

    PubMed  Google Scholar 

  8. Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GR, Roberts JM: Interleukin-2–mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570–3, 1994

    PubMed  Google Scholar 

  9. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J: Cloning of p27Kip1, a cyclindependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59–66, 1994

    Article  Google Scholar 

  10. Qian X, Jin L, Grande JP, Lloyd RV: Transforming growth factor-beta and p27 expression in pituitary cells. Endocrinology 137: 3051–60, 1996

    PubMed  Google Scholar 

  11. Reynisdottir I, Polyak K, Iavarone A, Massague J: Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 9: 1831–45, 1995

    PubMed  Google Scholar 

  12. Cave H, Gerard B, Martin E, Guidal C, Devaux I, Weissenbach J, Elion J, Vilmer E, Grandchamp B: Loss of heterozygosity in the chromosomal region 12p12–13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor suppressor gene distinct from p27KIP1. Blood 86, 3869–75, 1995

    PubMed  Google Scholar 

  13. Ferrando AA, Balbin M, Pendas AM, Vizoso F, Velasco G, Lopez-Otin C: Mutational analysis of the human cyclindependent kinase inhibitor p27kip1 in primary breast carcinomas. Hum Genet 97: 91–4, 1996

    PubMed  Google Scholar 

  14. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilcyznski S, LeeYY, Bartram CR, Koeffler HP: Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 55: 2266–9, 1995

    PubMed  Google Scholar 

  15. Kawamata N, Seriu T, Koeffler HP, Bartram CR: Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS/INK4A), p18(INK4C), and p27(Kip1) genes in neuroblastoma. Cancer 77: 570–5, 1996

    PubMed  Google Scholar 

  16. Pietenpol JA, Bohlander SK, Sato Y, Papadopoulos N, Liu B, Friedman C, Trask BJ, Roberts JM, KinzlerKW, Rowley JD, Vogelstein B: Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 55: 1206–10, 1995

    PubMed  Google Scholar 

  17. Ponce-Castaneda MV, Lee MH, Latres E, Polyak K, Lacombe L, Montgomery K, Mathew S, Krauter K, Sheinfeld J, Massague J, Cordon-Cardo C: p27Kip1: chromosomal mapping to 12p12–12p13.1 and absence of mutations in human tumors. Cancer Res 55: 1211–4, 1995

    PubMed  Google Scholar 

  18. Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler HP: p27/Kip1 mutation found in breast cancer. Cancer Res 56: 2400–4, 1996

    PubMed  Google Scholar 

  19. Stegmaier K, Takeuchi S, Golub TR, Bohlander SK, Bartram CR, Koeffler HP: Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Res 56: 1413–7, 1996

    PubMed  Google Scholar 

  20. Ikeda H, Yoshimoto T, Shida N: Molecular analysis of p21 and p27 genes in human pituitary adenomas. Br J Cancer 76: 1119–23, 1997

    PubMed  Google Scholar 

  21. Tanaka C, Yoshimoto K, Yang P, Kimura T, Yamada S, Moritani M, Sano T, Itakura M: Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas. J Clin Endocrinol Metab 82: 3141–7, 1997

    PubMed  Google Scholar 

  22. Zhu J, Leon SP, Beggs AH, Busque L, Gilliland DG, Black PM: Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J Clin Endocrinol Metab 78: 922–7, 1994

    PubMed  Google Scholar 

  23. Stegmaier K, Pendse S, Barker GF, Bray-Ward P, Ward DC, MontgomeryKT, Krauter KS, Reynolds C, Sklar J, Donnelly M, Bohlander SK, Rowley JD, Sallan SE, Gilliland DG, Golub TR: Frequent loss of heterozygosity at the TEL locus in acute lymphoblastic leukemia of childhood. Blood 86: 38–44, 1995

    PubMed  Google Scholar 

  24. Knudson AG, Jr: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820–3, 1971

    PubMed  Google Scholar 

  25. Lloyd RV, Jin L, Qian X, Kulig E: Aberrant p27kip1 expression in endocrine and other tumors. AmJ Pathol 150: 401–7, 1997

    Google Scholar 

  26. Jin L, Qian X, Kulig E, Sanno N, Scheithauer BW, Kovacs K, Young WF Jr, Lloyd RV: Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries. Am J Pathol 151: 509–19, 1997

    PubMed  Google Scholar 

  27. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 (see comments). Science 269: 682–5, 1995

    PubMed  Google Scholar 

  28. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas (see comments). Nat Med 3: 231–4, 1997

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. Jay Jiguang Zhu

    Present address: Faculty of Medicine, McGill University, Montreal, Quebec, Canada

Authors and Affiliations

  1. Neurosurgical Laboratories and Brain Tumor Center, Brigham and Women's Hospital, Children's Hospital, Dana Farber Cancer Institute, Department of Surgery, Harvard Medical School, Boston, MA, USA

    John C. Wilson, Jay Jiguang Zhu & Peter McL. Black

Authors
  1. John C. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jay Jiguang Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter McL. Black
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilson, J.C., Zhu, J.J. & Black, P.M. The p27/Kip1 Locus Shows No Loss of Heterozygosity in Human Pituitary Adenomas. J Neurooncol 44, 35–39 (1999). https://doi.org/10.1023/A:1006242118541

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006242118541

Search

Navigation